Outcomes and management of viral hepatitis and human immunodeficiency virus co-infection in liver transplantation

Table 1 Summary of outcomes post orthotopic liver transplant in hepatitis C virus/human immunodeficiency virus co-infection

Ref.1	Study period	Country	Patients	Median follow-up (mo)	Survival	Graft survival
Terrault et al[2]	2003-2010	United States	89	32	76% 1 yr	72% 1 yr
					60% 3 yr	53% 3 yr
Miro et al[41]	2002-2006	Spain	84	44	88% 1 yr	NR
					62% 3 yr
					54% 5 yr
Duclos-Vallée et al[43]	1999-2005	France	35	44	82% 1 yr	NR
					73% 2 yr
					51% 5 yr
De Vera et al[44]	1997-2005	United States	27	27	67% 1 yr	63% 1 yr
					56% 3 yr	52% 3 yr
					33% 5 yr	31% 5 yr
Ragni et al[94]	1997-2001	United States	15	17	80% 1 yr	NR
					57% 3 yr
					36% 5 yr
Vennarecci et al[95]	2002-2006	Italy	11	26	83% 1 yr	NR
					58% 3 yr2
Anadol et al[96]	1997-2011	Germany	19	613	58% 5 yr	NR

¹Studies with ≥ 10 patients;

²Survival reported for cohort of 12, including one hepatitis B virus/human immunodeficiency virus co-infected patient;

³For all patients. NR: Not reported.